| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5ad8562c578b061df7a2c3aee9d0e24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2300-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 |
| filingDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf28cdd4921b4d8a83e0101cd7e8a2bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd96c91492fbb096ecb0489307444c60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31272ca6f8a22649be48e115d894c6ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f78ce6bc338ad33a8d886b029f0ad7ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8497cd00f83787fff123d4c59096decc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03dcf3174a56cd27c2c32303cb99a6e7 |
| publicationDate |
2017-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170082812-A |
| titleOfInvention |
Anti-cancer composition comprising alcohol extracts of Selaginella tamariscina as an active ingredient for combinational administration with chemotherapeutics |
| abstract |
In this specification, an anticancer composition comprising an organic solvent extract of Buchucson as an active ingredient is disclosed. In one aspect, a composition containing bouchalcohol alcohol extract as an active ingredient can enhance the anticancer effect of a chemotherapeutic agent when it is administered in combination with a chemotherapeutic agent. When the composition is administered in combination, an excellent anti-cancer effect can be obtained even when a small amount of an anticancer agent is administered. Therefore, it is possible to reduce the dose of cytotoxic anticancer drug to healthy cells in addition to cancer cells, thereby effectively treating cancer while maintaining the health of cancer patients. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210072742-A |
| priorityDate |
2016-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |